Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor injection for digital nerve repair (phase II)
CTR20171505Phase 2Suspended
- Sponsor
- Staidson Biopharmaceutical
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mouse nerve growth factor in peripheral nerve injury (PNI), sponsored by Staidson Biopharmaceutical. Started Jan 2018; status: suspended.
02
Drugs
mouse nerve growth factor
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on CTR20171505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171505.